1.Beat diabetes: an urgent call for global action. Lancet. 2016. 387(10027):1483.
2.Korean Diabetes Association. Korean Diabetes Fact Sheet 2016 [Internet]. Seoul: Korean Diabetes Association;2016. [Accessed May 3, 2017]. Available from:. http://www.diabetes.or.kr/temp/KDA_fact_sheet%202016.pdf.
3.American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care. 2008. 31(3):596–615.
4.Peyrin-Biroulet L., Williet N., Cacoub P. Guidelines on the diagnosis and treatment of iron deficiency across indications: a systematic review. Am J Clin Nutr. 2015. 102(6):1585–94.
Article
5.Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999. 340(6):448–54.
Article
6.Opara EC. Role of oxidative stress in the etiology of type 2 diabetes and the effect of antioxidant supplementation on glycemic control. J Investig Med. 2004. 52(1):19–23.
Article
7.Evans JL., Maddux BA., Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. 2005. 7(7-8):1040–52.
Article
8.Pradhan AD., Manson JE., Rifai N., Buring JE., Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001. 286(3):327–34.
Article
9.Rajpathak SN., Wylie-Rosett J., Gunter MJ., Negassa A., Kabat GC., Rohan TE, et al. Biomarkers of body iron stores and risk of developing type 2 diabetes. Diabetes Obes Metab. 2009. 11(5):472–9.
Article
10.Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006. 444(7121):860–7.
Article
11.Wilson JG., Lindquist JH., Grambow SC., Crook ED., Maher JF. Potential role of increased iron stores in diabetes. Am J Med Sci. 2003. 325(6):332–9.
Article
12.Jiang R., Manson JE., Meigs JB., Ma J., Rifai N., Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA. 2004. 291(6):711–7.
Article
13.Lee BK., Kim Y., Kim YI. Association of serum ferritin with metabolic syndrome and diabetes mellitus in the South Korean general population according to the Korean National Health and Nutrition Examination Survey 2008. Metabolism. 2011. 60(10):1416–24.
Article
14.Kim S., Park SK., Ryoo JH., Choi JM., Hong HP., Park JH, et al. Incidental risk for diabetes according to serum ferritin concentration in Korean men. Clin Chim Acta. 2015. 451(Pt B):165–9.
Article
15.Kim CH., Kim HK., Bae SJ., Park JY., Lee KU. Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metabolism. 2011. 60(3):414–20.
Article
16.Park RJ., Moon JD. Low transferrin saturation is associated with impaired fasting glucose and insulin resistance in the South Korean adults: the 2010 Korean National Health and Nutrition Examination Survey. Diabet Med. 2015. 32(5):673–8.
Article
17.Kim I., Yetley EA., Calvo MS. Variations in iron-status measures during the menstrual cycle. Am J Clin Nutr. 1993. 58(5):705–9.
Article
18.Powell LW., Seckington RC., Deugnier Y. Haemochromatosis. Lancet. 2016. 388(10045):706–16.
Article
19.Fernández-Real JM., Ricart-Engel W., Arroyo E., Balançá R., Casamitjana-Abella R., Cabrero D, et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care. 1998. 21(1):62–8.
Article
20.Evans JL., Maddux BA., Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. 2005. 7(7-8):1040–52.
Article
21.Davis RJ., Corvera S., Czech MP. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem. 1986. 261(19):8708–11.
Article